Digital Intervention for Suicide Prevention in Cyberbullied Adolescents
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital tool called Flourish, designed to assist young people who have experienced cyberbullying and are at risk for suicide. The researchers aim to determine if Flourish can enhance problem-solving skills, manage distress, and reduce suicidal thoughts more effectively than completing questionnaires alone. English-speaking teens who have been cyberbullied in the last three months and have felt suicidal may qualify for this study. Participants will either use the Flourish tool alongside questionnaires or only complete questionnaires to compare outcomes. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could shape future support tools for cyberbullying victims.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.
What prior data suggests that the Flourish digital intervention is safe for cyberbullied adolescents?
Research shows that Flourish, a digital tool for preventing suicide, is safe and well-liked. Studies with similar groups, such as LGBTQ+ youth who have experienced online bullying, have found Flourish to be helpful. Participants used it without major issues, indicating it is generally well-tolerated.
Although large-scale studies specifically on Flourish's safety are lacking, it is being tested with individuals who often face mental health challenges. Early results suggest it might aid in problem-solving and reducing distress, indicating a positive safety profile, as past research has reported no serious problems.
Since the trial is in its early stages, researchers aim to understand how Flourish works and how people respond to it, rather than proving its safety and effectiveness on a large scale. So far, Flourish appears to be a safe option for those considering joining the trial.12345Why are researchers excited about this trial?
Researchers are excited about the Flourish digital intervention for suicide prevention in cyberbullied adolescents because it offers a unique approach by combining digital support with regular feedback on online experiences. Unlike traditional methods that may rely on therapy sessions or medications, Flourish provides continuous support through a text messaging program, which is easily accessible and can be integrated into the daily lives of adolescents. Additionally, the intervention includes a resources website, offering participants further tools and information to help manage their experiences. This innovative approach could offer timely support and empower adolescents to navigate cyberbullying more effectively.
What evidence suggests that this digital intervention is effective for suicide prevention in cyberbullied adolescents?
Research shows that Flourish, a digital tool formerly known as imHere4U, aims to reduce suicidal thoughts in teenagers bullied online. In this trial, some participants will use Flourish along with completing questionnaires. Studies have found that digital tools like Flourish can enhance problem-solving and stress management skills, crucial for addressing emotional issues. Early results suggest that users of similar digital tools feel more motivated and less stressed. The program also offers feedback on online interactions, which participants have found helpful and easy to use. Although still under study, these factors suggest that Flourish could effectively support at-risk youth.46789
Who Is on the Research Team?
Candice L Biernesser, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for English-speaking adolescents aged 12-17 who have experienced cyberbullying and are at risk of suicide, evidenced by distress or suicidal thoughts. They must be able to text and not require a higher level of care like hospitalization.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Onboarding
Adolescents and their caregivers participate in a session to onboard to Flourish, including orientation and personalization of the intervention
Intervention
Participants receive the Flourish intervention or Questionnaires Alone for 4 weeks, with interactions approximately 2-3 times per week
Follow-up
Participants are monitored for changes in suicidal ideation, psychological distress, and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Flourish
- Questionnaires
Trial Overview
The study tests 'Flourish,' a digital intervention aimed at preventing suicide among cyberbullied youth, comparing it with just answering questionnaires. It also explores the use of machine learning feedback on social media interactions.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be onboarded to Flourish by a research study clinician, following which they will receive a text messaging program for 4 weeks as well as an accompanying resources website. As part of the text messaging program, participants will receive brief questionnaires evaluating their online experiences once every 3 days.
Participants will be onboarded to a text message program that solely will send participants brief questionnaires evaluating their online experiences once every 3 days.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Published Research Related to This Trial
Citations
Development and Testing of ImHere4U: a Digital Suicide ...
The objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital ...
2.
reporter.nih.gov
reporter.nih.gov/search/14EACD094D84C7D77598B8961CAA4A01A2FFCEB861BF/project-details/10904924Development and Testing of imHere4U: A Digital Suicide Prevention ...
A complementary research plan will focus on development and testing of imHere4U, a just-in- time, suicide prevention intervention for cyberbullied adolescents.
A digital suicide prevention intervention for LGBTQ+ youth ...
Next steps will include testing the feasibility and efficacy of Flourish through controlled trials and examining effectiveness and implementation outcomes ...
Research Roundup June 2024: Recently Published ...
The Research Roundup is a regular update of recently published findings in suicide prevention research.
5.
aging.networkofcare.org
aging.networkofcare.org/sanmateo/CommunityResources/ClinicalTrials/Detail/NCT06002191?keyword=%22Suicidal%20Ideation%22San Mateo Clinical Trial Development and Testing of imHere4U
~H2b. Secondary outcomes: Youth assigned to Flourish+Questionnaires will report improved problem-solving capacity, distress tolerance, and motivation and ...
Project Details - NIH RePORTER
Suicide is the second leading cause of death among adolescents, and youth who are cyberbullied are twice as likely to exhibit suicidal thoughts and ...
A digital suicide prevention intervention for LGBTQ+ youth ...
To address these gaps, this study aims to develop Flourish, a digital suicide prevention intervention for LGBTQ+ youth who have experienced OV.
Digital Intervention for Suicide Prevention in Cyberbullied ...
H2b. Secondary outcomes: Youth assigned to Flourish+Questionnaires will report improved problem-solving capacity, distress tolerance, and motivation and reduced ...
Social Media and Adolescent Suicide
Draws upon criteria for cyberbullying: Willful and repeated harm inflicted through the use of computers, cell phones, and other electronic ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.